BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6170701)

  • 1. Human C5a des Arg increases vascular permeability.
    José PJ; Forrest MJ; Williams TJ
    J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
    Movat HZ; Rettl C; Burrowes CE; Johnston MG
    Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular permeability changes induced by complement-derived peptides.
    Williams TJ
    Agents Actions; 1983 Aug; 13(5-6):451-5. PubMed ID: 6195896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.
    Williams TJ; Jose PJ
    J Exp Med; 1981 Jan; 153(1):136-53. PubMed ID: 6161204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J; Hugli TE; Smedegård G
    J Immunol; 1985 Feb; 134(2):1115-9. PubMed ID: 3871207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human anaphylatoxins on guinea pig atria.
    Huey R; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    Stimler NP; Bach MK; Bloor CM; Hugli TE
    J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW
    J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of histamine from rat mast cells by the complement peptides C3a and C5a.
    Johnson AR; Hugli TE; Müller-Eberhard HJ
    Immunology; 1975 Jun; 28(6):1067-80. PubMed ID: 48505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.
    Larsen GL; McCarthy K; Webster RO; Henson J; Henson PM
    Am J Pathol; 1980 Jul; 100(1):179-92. PubMed ID: 7395964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.